Investigating pharmacology profiles of TLR7 agonists in a mouse model of lymphopenia

被引：0
|
作者：
Perkins, H. [1 ]
Khodai, T. [1 ]
Mechiche, H. [1 ]
Colman, P. [1 ]
Burden, F. [1 ]
Laxton, C. [1 ]
Horscroft, N. [1 ]
Corey, T. [1 ]
Rodrigues, D. [1 ]
Rawal, J. [1 ]
Webster, R. [1 ]
Heyen, J. [2 ]
Westby, M. [1 ]
Bright, H. [1 ]
机构：
[1] Pfizer, Sandwich, Kent, England
[2] Pfizer, San Diego, CA USA
来源：
IMMUNOLOGY | 2010年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [21] Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants
    Smith, Alyson J.
    Li, Yufeng
    Bazin, Helene G.
    St-Jean, Julien R.
    Larocque, Daniel
    Evans, Jay T.
    Baldridge, Jory R.
    VACCINE, 2016, 34 (36) : 4304 - 4312
  • [22] New TLR7 agonists with improved humoral and cellular immune responses
    Upchurch, Katherine C.
    Boquin, Jose R.
    Yin, Wenjie
    Xue, Yaming
    Joo, HyeMee
    Kane, Robert R.
    Oh, SangKon
    IMMUNOLOGY LETTERS, 2015, 168 (01) : 89 - 97
  • [23] Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists
    Collier, Michael A.
    Junkins, Robert D.
    Gallovic, Matthew D.
    Johnson, Brandon M.
    Johnson, Monica M.
    Macintyre, Andrew N.
    Sempowski, Gregory D.
    Bachelder, Eric M.
    Ting, Jenny P. -Y.
    Ainslie, Kristy M.
    MOLECULAR PHARMACEUTICS, 2018, 15 (11) : 4933 - 4946
  • [24] TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists
    Proskocil, Becky
    Fryer, Allison
    Jacoby, David
    Drake, Matthew
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [25] Conjugation of TLR7 and TLR7/8 agonists onto weak protein antigen via versatile oxime ligation for enhanced vaccine efficacy
    Zhang, Ru-Yan
    Wen, Yu
    He, Chen-Bin
    Zhou, Shi-Hao
    Wu, Ye-Hui
    Wang, En-Yang
    Feng, Ran-Ran
    Ding, Dong
    Du, Jing-Jing
    Gao, Xiao-Fei
    Guo, Jun
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 278
  • [26] Dual TLR2 and TLR7 agonists as HIV latency-reversing agents
    Macedo, Amanda B.
    Novis, Camille L.
    De Assis, Caroline M.
    Sorensen, Eric S.
    Moszczynski, Paula
    Huang, Szu-han
    Ren, Yanqin
    Spivak, Adam M.
    Jones, R. Brad
    Planelles, Vicente
    Basque, Alberto
    JCI INSIGHT, 2018, 3 (19):
  • [27] Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists
    Hamm, Svetlana
    Rath, Sandra
    Michel, Susanne
    Baumgartner, Roland
    JOURNAL OF IMMUNOTOXICOLOGY, 2009, 6 (04) : 257 - 265
  • [28] Role of TLR7 and TLR9 in a murine model of SLE
    Santiago-Raber, M-L.
    Borel, P.
    Uematsu, S.
    Akira, S.
    Izuil, S.
    SWISS MEDICAL WEEKLY, 2008, 138 : 15S - 15S
  • [29] Dissecting in vivo innate immune responses to TLR7/9 agonists in primates
    Puig, Montserrat
    Grajkowska, Lucja T.
    Mattapallil, Joseph J.
    Verthelyi, Daniela
    CYTOKINE, 2009, 48 (1-2) : 100 - 100
  • [30] Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
    Alharbi, Arwaf S.
    Garcin, Aurelie J.
    Lennox, Kim A.
    Pradeloux, Solene
    Wong, Christophe
    Straub, Sarah
    Valentin, Roxane
    Pepin, Genevieve
    Li, Hong-Mei
    Nold, Marcel F.
    Nold-Petry, Claudia A.
    Behlke, Mark A.
    Gantier, Michael P.
    NUCLEIC ACIDS RESEARCH, 2020, 48 (13) : 7052 - 7065
12345